MedTrace Logo

Persistent SARS-CoV-2 Infection in Children With Cancer and Impaired Immune Responsiveness

NCT05172063 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2021-12-29

No results posted yet for this study

Summary

The main goal of this study is to characterize the adaptive immune responses to SARS-CoV-2 infection in a cohort of children with cancer and impaired immune responsiveness and prolonged viral shedding of SARS-CoV-2, and to identify SARS-CoV-2 variants that might arise during poorly controlled virus replication

Conditions

Sponsors & Collaborators

  • National Research Centre, Egypt

    collaborator OTHER

  • Pfizer

    collaborator INDUSTRY

  • Children's Cancer Hospital Egypt 57357

    lead OTHER

Principal Investigators

  • Mohamed Diaaeldin Hashem, MBBCh, MSc · Children's Cancer Hospital Egypt

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-31
Primary Completion
2023-03-31
Completion
2023-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05172063 on ClinicalTrials.gov